April 21 (Reuters) - Amgen Inc reported higher first-quarter earnings on Tuesday, driven by price increases for its biggest-selling drugs, as well as lower spending on research and development.
The Thousand Oaks, California, drugmaker posted a quarterly net profit of $1.62 billion, or $2.11 per share, a 51 percent increase from $1.07 billion, or $1.40 per share, a year earlier.
13:48 Wells Fargo Profit Falls 5.4% as Mortgage Revenue Declines23
12:08 Bank of America Profit Rises 43% on Trading Gains, Cost Cuts22
12:02 Bank of America tops earnings forecast, predicts 'significant increase' in net interest income20
10:27 India's Tata Consultancy third-quarter net up 10.9 percent, beats estimates20